Effects of anti-TNF-alpha antibody infliximab in refractory entero-Behcet's disease

Rheumatology (Oxford). 2009 Aug;48(8):1012-3. doi: 10.1093/rheumatology/kep126. Epub 2009 May 22.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antibodies, Monoclonal / therapeutic use*
  • Behcet Syndrome / complications
  • Behcet Syndrome / drug therapy*
  • Female
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Infliximab
  • Intestinal Diseases / complications
  • Intestinal Diseases / drug therapy*
  • Male
  • Middle Aged
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*
  • Young Adult

Substances

  • Antibodies, Monoclonal
  • Immunosuppressive Agents
  • Tumor Necrosis Factor-alpha
  • Infliximab